Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Phreesia, Inc. (NYSE: PHR) between May 8, 2025 and March 30, 2026.
ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 billion.Inflammasome ASC Inhibitor IC 100 is the next evolution o ...
Kansas' Darryn Peterson, BYU's AJ Dybantsa, Duke’s Cameron Boozer and North Carolina’s Caleb Wilson are considered potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results